Duplications of the PMP22 gene, which encodes peripheral myelin protein 22 (PMP22), are responsible for the most prevalent form of Charcot–Marie–Tooth disease (CMT), known as CMT1A.1,2 CMT1A patients exhibit a dysmyelinating phenotype in their peripheral nerves and may experience mild-to-severe muscular atrophy in the distal regions of their body, with some also presenting with sensory abnormalities.3 PMP22 is a membrane glycoprotein constituting 2%–5% of compact myelin of the peripheral nervous system, which is produced primarily by Schwann cells.4 Here, PMP22 is linked to muscular atrophy.